<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
A screening of healthcare stocks in the S&P 500 reveals that investors may find plenty of upside in three members of the index, according to an article in Barron’s. The analysis showed that Vertex Pharmaceuticals ( VRTX , Financial), Viatris Inc. ( VTRS , Financial) and Incyte Corp. ( INCY , Financial) all sell at deep discounts to price forecasts by Wall Street analysts.
...read full article on GuruFocus
